CIK 0001858848 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Net income (USD) | -90.6 M | -124.1 M | -123.7 M |
| Diluted EPS (USD/shares) | -0.59 | -1.68 | -2.76 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-23 | DEFA14A | DEFA14A | |
| 2026-10-23 | DEF 14A | DEF 14A | 2026-12-09 |
| 2026-10-13 | PRE 14A | PRE 14A | 2026-12-09 |
| 2026-09-11 | 4 | 4 | 2026-09-10 |
| 2026-09-11 | 4 | 4 | 2026-09-10 |
| 2026-08-24 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-17 | 4 | 4 | 2026-08-17 |
| 2026-08-17 | 4 | 4 | 2026-08-17 |
| 2026-08-17 | 144 | 144 | |
| 2026-08-17 | 144 | 144 | |
| 2026-08-05 | S-8 | S-8 | |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-07-14 | 3 | 3 | 2026-07-13 |
| 2026-07-14 | 4 | 4 | 2026-07-13 |
| 2026-07-02 | 8-K | 8-K items 1.02 | 2026-06-29 |
| 2026-06-29 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-06-29 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 4 | 4 | 2026-05-28 |
| 2026-05-29 | 8-K | 8-K items 5.02,5.07,9.01 | 2026-05-27 |
Forms on file (last 1,000): 4 124, 8-K 53, 144 26, 3 20, 10-Q 16, SC 13G/A 10, SC 13G 10, S-8 8. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=TNYA (0.002 USD), /gw/filings/filings?ticker=TNYA&form=8-K, /gw/filings/facts?ticker=TNYA&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange